ArticleFrontiers in immunology2024

Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap.

Malak Alharbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.